IQVIA Holdings Inc
IQV187.490USD
+6.530+3.61%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
31.80BMarket Cap
23.70P/E TTM
More Details of IQVIA Holdings Inc Company
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
IQVIA Holdings Inc Info
Ticker SymbolIQV
Company nameIQVIA Holdings Inc
IPO dateMay 09, 2013
CEOBousbib (Ari)
Number of employees88000
Security typeOrdinary Share
Fiscal year-endMay 09
Address2400 Ellis Road
CityDURHAM
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code27703
Phone19199982000
Websitehttps://ir.iqvia.com/
Ticker SymbolIQV
IPO dateMay 09, 2013
CEOBousbib (Ari)
Company Executives of IQVIA Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-907.00%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-117138.00%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+1592.00%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+1592.00%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+1047.00%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+1676.00%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
+1047.00%
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-84.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-907.00%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-117138.00%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+1592.00%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+1592.00%
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Americas
1.93B
47.15%
Europe & Africa Region
1.30B
31.63%
Asia Pacific Region
870.00M
21.22%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Jan 10
Updated: Sat, Jan 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.49%
Harris Associates L.P.
6.69%
BlackRock Institutional Trust Company, N.A.
5.54%
State Street Investment Management (US)
4.43%
GIC Private Limited
3.84%
Other
68.00%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.49%
Harris Associates L.P.
6.69%
BlackRock Institutional Trust Company, N.A.
5.54%
State Street Investment Management (US)
4.43%
GIC Private Limited
3.84%
Other
68.00%
Shareholder Types
Shareholders
Proportion
Investment Advisor
47.52%
Investment Advisor/Hedge Fund
36.26%
Sovereign Wealth Fund
4.94%
Pension Fund
4.13%
Hedge Fund
3.23%
Research Firm
2.36%
Bank and Trust
2.00%
Individual Investor
0.92%
Family Office
0.15%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
2121
171.05M
100.44%
-15.70M
2025Q3
2061
175.98M
103.33%
-829.63K
2025Q2
2053
166.70M
98.05%
-9.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
19.41M
11.4%
-186.59K
-0.95%
Sep 30, 2025
Harris Associates L.P.
11.39M
6.69%
-365.92K
-3.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.44M
5.54%
+67.42K
+0.72%
Sep 30, 2025
State Street Investment Management (US)
7.55M
4.43%
-75.92K
-1.00%
Sep 30, 2025
GIC Private Limited
6.54M
3.84%
-2.59M
-28.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.35M
2.55%
+132.36K
+3.14%
Sep 30, 2025
CPP Investments
4.12M
2.42%
-52.91K
-1.27%
Sep 30, 2025
AllianceBernstein L.P.
3.60M
2.11%
+41.64K
+1.17%
Sep 30, 2025
Boston Partners
3.56M
2.09%
+1.58M
+80.09%
Sep 30, 2025
Artisan Partners Limited Partnership
3.43M
2.02%
+161.09K
+4.92%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
9.1%
Langar Global HealthTech ETF
7.83%
Global X HealthTech ETF
5.5%
VanEck Biotech ETF
4.98%
iShares Biotechnology ETF
3.23%
iShares Health Innovation Active ETF
3.05%
Adaptive Core ETF
3.04%
Invesco Bloomberg Pricing Power ETF
2.24%
Running Oak Efficient Growth ETF
2.16%
Invesco Zacks Mid-Cap ETF
2.08%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion9.1%
Langar Global HealthTech ETF
Proportion7.83%
Global X HealthTech ETF
Proportion5.5%
VanEck Biotech ETF
Proportion4.98%
iShares Biotechnology ETF
Proportion3.23%
iShares Health Innovation Active ETF
Proportion3.05%
Adaptive Core ETF
Proportion3.04%
Invesco Bloomberg Pricing Power ETF
Proportion2.24%
Running Oak Efficient Growth ETF
Proportion2.16%
Invesco Zacks Mid-Cap ETF
Proportion2.08%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
